The Result Is Not The Decision
Accurate infectious disease testing is only part of the equation. The final, and often most important, step is turning those results into the right clinical treatment decision. Join Dr. Ari Frenkel and Kelly Chauvin, PharmD, of Molecular Testing Labs for a candid conversation about what happens between the lab result and the clinical decision, and why that gap matters.
Presented by Arkstone Medical Solutions with Molecular Testing Labs, an Arkstone Qualified Lab.
Why the prescribing decision matters.
Antimicrobial resistance shapes prescribing decisions every day, often in settings with no infectious disease specialist on hand. This session covers what getting that decision right means in practice: better patient outcomes, lower cost of care, lower risk and less resistance downstream.
The pressure at the point of prescribing
Why antimicrobial resistance matters now, the pressure clinicians face at the point of prescribing and the shortage of infectious disease expertise in most care settings.
What the panels detect
Molecular Testing Labs on their approach to accuracy and quality, what their infectious disease panels identify and how they think about access to testing.
Where testing meets the decision
A detailed result arrives and the clinician still has to decide what to do with it. What happens in that gap and what changes when interpretation arrives with the result.
Real cases and outcomes
A provider case from start to finish: what was ordered, what came back, what was decided and what happened for the patient. Plus what changed for the lab and its clients in practice.
Your questions, answered live
Submit questions in advance at registration or ask them live. Dr. Frenkel moderates an open Q&A with the panel in the final segment.
Meet the speakers.
An hour of discussion between an infectious disease physician and a laboratory scientist, with time for your questions.
Dr. Ari Frenkel, MD MPH
Infectious disease physician and co-founder of Arkstone Medical Solutions, where he leads the clinical side of OneChoice, Arkstone's interpretive reporting and antimicrobial decision support. Dr. Frenkel hosts the Prescribe Responsibly podcast.
Kelly Chauvin, PharmD
Pharmacist and medical science liaison at Molecular Testing Labs, a CLIA-certified and CAP-accredited high-complexity laboratory. Kelly works at the intersection of laboratory science and clinical practice, helping providers understand what molecular panels detect and how to act on them responsibly.
Who should attend.
For anyone who orders infectious disease testing, interprets results or sets antimicrobial stewardship standards.
Save your seat.
Free to attend. Every registrant receives the recording, so sign up even if you cannot join live.
Save my seatThis session is for educational purposes only and does not constitute medical advice. The webinar will be recorded. By registering you agree to receive the recording and related follow up from Arkstone Medical Solutions and Molecular Testing Labs.